BRÈVE

sur Straumann Holding AG (isin : CH0012280076)

Straumann Group Reports Robust Organic Growth in Q3 2024

Straumann Holding AG announced a notable 11.2% organic revenue increase in Q3 2024, reaching CHF 585.5 million. This growth brings the year-to-date revenue to approximately CHF 1.9 billion, with a 14.5% organic rise. The Europe, Middle East, and Africa region notably contributed with an 11.4% organic increase in the quarter. Meanwhile, Asia Pacific stood out with the highest regional growth of 19.7%, driven by strong implantology performance. North America saw modest growth of 2.0%, despite a challenging implantology market. Latin America maintained its strength with an 18.9% organic growth, notably through the Neodent brand.

Straumann also highlighted strategic advances, including the global launch of the SIRIOS intraoral scanner and ongoing investments in capacity expansion, notably a new Neodent factory in Brazil. CEO Guillaume Daniellot expressed confidence in sustaining growth, reaffirming the 2024 outlook for low double-digit organic revenue growth and 27-28% profitability.

R. E.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Straumann Holding AG